But you get this concept where the brain isn't wanting food, your body's telling you, I don't need food
Mounjaro and Zepbound Tirzepatide, the active ingredient in Mounjaro and Zepbound, offers a unique dual mechanism of action by targeting both GLP-1 and GIP receptors
These results align with emerging evidence of GSK3 as a target in cardiac mitochondrial dysfunction
Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist approved by the FDA for the treatment of type 2 diabetes mellitus under the brand name Mounjaro and for chronic weight management as Zepbound
Ketone Bodies During periods of fasting and some other physiological conditions, water-soluble molecules that may contain a ketone group, such as acetoacetate, hydroxybutyrate, and the spontaneous breakdown product of acetoacetate, acetone, are produced from acetyl-coA by the liver after oxidation of fatty acids
Nicola Magrini, Unit head for Innovation, Evidence synthesis and Clinical research, University Hospital, Bologna, Italy, Co-Chair of the Guidelines Development Group Comments: GLP-1 and inclusion in the essential medicine Mr Deus Mubangizi, Director, Medicines and Health Products Policies and Standards Department, WHO Panel discussion Ms Jeanette Hunter General Primary Health Care at the National Department of Health (NDoH) of South Africa, and Co-Chair of the Guidelines Development Group